ASTH
Astrana Health, Inc.Company with tickers: ASTH
CIK
1083446
CUSIP
03763A207
Shares Outstanding
49,583,418
13F Activity (30d)
36 filings
36 filers
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
| Fiscal Year Ended | Cash Spent | Source |
|---|---|---|
| 2026-03-31 YTD | $2,800,000 | 10-Q, filed 2026-05-08 |
| 2025-12-31 | $25,600,000 | 10-K, filed 2026-03-12 |
| 2024-12-31 | $900,000 | 10-K, filed 2026-03-12 |
| 2023-12-31 | $10,192,000 | 10-K, filed 2024-02-29 |
| 2022-12-31 | $9,250,000 | 10-K, filed 2024-02-29 |
| 2021-12-31 | $5,739,000 | 10-K, filed 2024-02-29 |
| 2020-12-31 | $537,000 | 10-K/A, filed 2023-08-09 |
| 2019-12-31 | $7,570,000 | 10-K, filed 2022-02-28 |
| 2018-12-31 | $5,047,000 | 10-K, filed 2021-03-15 |
| 2017-12-31 | $3,175,836 | 10-K, filed 2020-03-16 |
| 2016-12-31 | $517,500 | 10-K, filed 2018-04-02 |
| 2015-03-31 | $500 | 10-K, filed 2015-07-14 |
| 2014-01-31 | $0 | 10-K, filed 2015-07-14 |
Recent quarters
| Quarter Ended | Cash Spent | Source |
|---|---|---|
| 2026-03-31 | $2,800,000 | 10-Q, filed 2026-05-08 |
| 2025-12-31 | $15,000,000 Δ | 10-K, filed 2026-03-12 |
| 2025-09-30 | $0 Δ | 10-Q, filed 2025-11-10 |
| 2025-06-30 | $0 Δ | 10-Q, filed 2025-08-07 |
| 2025-03-31 | $10,600,000 | 10-Q, filed 2025-05-09 |
| 2024-12-31 | $900,000 Δ | 10-K, filed 2026-03-12 |
| 2024-09-30 | $0 Δ | 10-Q, filed 2025-11-10 |
| 2023-12-31 | $503,000 Δ | 10-K, filed 2024-02-29 |
| 2023-09-30 | $150,000 Δ | 10-Q, filed 2023-11-09 |
| 2023-06-30 | $9,539,000 Δ | 10-Q, filed 2023-08-09 |
| 2023-03-31 | $0 | 10-Q/A, filed 2023-08-09 |
| 2022-09-30 | $168,000 Δ | 10-Q, filed 2023-11-09 |